fullerene c60 has been researched along with 2-phenylquinoline in 2 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (2-phenylquinoline) | Trials (2-phenylquinoline) | Recent Studies (post-2010) (2-phenylquinoline) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 35 | 0 | 20 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toshima, K | 1 |
| Takahashi, D; Tanimoto, S; Toshima, K | 1 |
1 review(s) available for fullerene c60 and 2-phenylquinoline
| Article | Year |
|---|---|
Target-selective degradation of proteins and oligosaccharides by light-activated hybrid molecules for molecular-targeted photodynamic therapy.
Topics: Animals; Anthraquinones; Antigens, Viral, Tumor; Estrogen Receptor alpha; Fullerenes; HIV Protease; Light; Models, Molecular; Molecular Structure; Oligosaccharides; Photochemotherapy; Photosensitizing Agents; Proteins; Quinolines; Steroids | 2009 |
1 other study(ies) available for fullerene c60 and 2-phenylquinoline
| Article | Year |
|---|---|
Chemical methods for degradation of target proteins using designed light-activatable organic molecules.
Topics: Amyloid beta-Peptides; Animals; Cell Line; Estrogen Receptor alpha; Fullerenes; HIV Protease; Humans; Monosaccharides; Photolysis; Photosensitizing Agents; Porphyrins; Proteolysis; Quinolines; Rats; Steroids; Sulfonic Acids; Ultraviolet Rays | 2012 |